This study is a pilot randomized clinical trial designed to test whether it is feasible to conduct a larger study comparing two standard treatments for mild degenerative cervical myelopathy (DCM). The main questions it aims to answer are: * Can enough participants be recruited and successfully complete follow-up assessments? * Will participants adhere to their assigned treatment? Researchers will compare two groups: * Surgical group: Participants receive decompressive spine surgery (with or without fusion). * Conservative care group: Participants follow a structured program that includes education, fall prevention strategies, and tailored exercises. Participants will: * Complete baseline and follow-up assessments at 6 weeks, 6 months, and 12 months. * In the surgical group: undergo surgery within 12 weeks of randomization and receive standard post-operative care. * In the conservative care group: follow a 6-week progressive exercise program and continue self-management strategies. * Complete a monthly online symptom monitoring questionnaire
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Enrollment
56
Surgical decompression of the cervical spine
Conservative care Program for cervical myelopathy
Consent proportion
Total number of participants randomized/ total number of patients approached
Time frame: Enrollment
Follow-up completion
Number of participants with 6-month follow up completed/ number of participants randomized
Time frame: 6 month follow-up
Adherence to intervention
Number of participants who proceed with allocated intervention/ number of participants randomized
Time frame: 6 months after enrollment
Patient-derived Modified Japanese Orthopaedic Association Scale (P-mJOA)
Patient reported outcome assessing (i) upper extremity sensation, (ii) upper extremity motor function, (iii) lower extremity motor function, and (iv) sphincter function. It is used to grade DCM severity, and scored between 0 and 18. Scores of 18 indicate no dysfunction, 15 to 17 indicate mild DCM, 12 to 14 indicate moderate DCM, 11 and lower indicating severe DCM.
Time frame: Baseline, 6 months, 12 months
Cervical Myelopathy Severity Index (CMSI)
The Cervical Myelopathy Severity Index (CSMI) assesses neurological function. It is a patient-completed 14-item measure for patients with DCM to evaluate symptom severity and functional limitations. Items span dexterity, balance/gait, pain, sensory impairment, and sphincter dysfunction. Each item is rated on a 4-point scale, from 0 (no difficulty), to 3 (severe difficulty). Total scores range from 0-42, with a higher score indicating higher DCM severity.
Time frame: Baseline, 6 months, 12 months
Neck Disability Index (NDI)
The NDI is a continuous measure ranging from 0 to 100 with higher scores indicating more severe disability.
Time frame: Baseline, 6 months, 12 months
Arm and Shoulder Pain
This will be measured using the 11-point Numerical Rating Scale (NRS), where 0 is 'no pain' and 10 is 'worst possible pain'.
Time frame: Baseline, 6 months, 12 months
Upper Extremity Neurologic Function
This will be measured using the grip-and-release test (G\&R test). Participants are asked to grip and release with the fingers as rapidly as possible with the forearm kept in pronation and the wrist in mild extension. The number of complete cycles of movement within 10 seconds are counted.
Time frame: Baseline, 6 months, 12 months
Lower Extremity Neurologic Function
This will be measured using the 30-m walking test (30MWT). Participants are asked to walk a straight 30-meter distance as quickly as possible with any normally used walking aids; number of steps and time is recorded.
Time frame: Baseline, 6 months, 12 months
Falls
Falls will be assessed using questions one and two of the modified American Geriatric/British Geriatric tool: "How many times have you fallen since the last visit?" and "Since the last visit, did you seek medical care for a fall injury?"
Time frame: Baseline, 6 months, 12 months
Dysphagia
Dysphagia will be assessed using the Bazaz Scoring System. This classifies patient reported swallowing difficulty into 4 categories: none, mild, moderate, severe.
Time frame: Baseline, 6 months, 12 months
Need for additional cervical spine surgery
This will be assessed and collected from patient self-report and medical records.
Time frame: Up to 12 months after the intervention.
Adverse Events
Occurrence of related adverse events will be monitored at every scheduled and unscheduled clinic visit.
Time frame: Through study completion, up to 12 months after intervention.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.